441 related articles for article (PubMed ID: 19698701)
1. Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease.
Sun Y; Wu XX; Yin Y; Gong FY; Shen Y; Cai TT; Zhou XB; Wu XF; Xu Q
Biochem Pharmacol; 2010 Jan; 79(2):229-38. PubMed ID: 19698701
[TBL] [Abstract][Full Text] [Related]
2. Jaceosidin inhibits contact hypersensitivity in mice via down-regulating IFN-γ/STAT1/T-bet signaling in T cells.
Yin Y; Sun Y; Gu L; Zheng W; Gong F; Wu X; Shen Y; Xu Q
Eur J Pharmacol; 2011 Jan; 651(1-3):205-11. PubMed ID: 21093428
[TBL] [Abstract][Full Text] [Related]
3. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
4. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
[TBL] [Abstract][Full Text] [Related]
5. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.
Zhou R; Wang JX; Tang W; He PL; Yang YF; Li YC; Li XY; Zuo JP
Acta Pharmacol Sin; 2006 Dec; 27(12):1616-21. PubMed ID: 17112417
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
Aharoni R; Sonego H; Brenner O; Eilam R; Arnon R
Immunol Lett; 2007 Oct; 112(2):110-9. PubMed ID: 17719654
[TBL] [Abstract][Full Text] [Related]
7. (5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA/1 mice via suppressing interferon-gamma production and its related signaling.
Zhou R; Tang W; Ren YX; He PL; Zhang F; Shi LP; Fu YF; Li YC; Ono S; Fujiwara H; Yang YF; Zuo JP
J Pharmacol Exp Ther; 2006 Jul; 318(1):35-44. PubMed ID: 16574782
[TBL] [Abstract][Full Text] [Related]
8. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
9. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
10. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
11. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
[TBL] [Abstract][Full Text] [Related]
12. Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis.
Kanai T; Uraushihara K; Totsuka T; Nemoto Y; Fujii R; Kawamura T; Makita S; Sawada D; Yagita H; Okumura K; Watanabe M
J Gastroenterol Hepatol; 2006 Jul; 21(7):1136-42. PubMed ID: 16824065
[TBL] [Abstract][Full Text] [Related]
13. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
15. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.
Pender SL; Chance V; Whiting CV; Buckley M; Edwards M; Pettipher R; MacDonald TT
Gut; 2005 Aug; 54(8):1114-20. PubMed ID: 16009684
[TBL] [Abstract][Full Text] [Related]
17. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis.
Chang JH; Kim YJ; Han SH; Kang CY
Eur J Immunol; 2009 May; 39(5):1241-51. PubMed ID: 19337996
[TBL] [Abstract][Full Text] [Related]
19. Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis.
Mencarelli A; Distrutti E; Renga B; Cipriani S; Palladino G; Booth C; Tudor G; Guse JH; Hahn U; Burnet M; Fiorucci S
Eur J Pharmacol; 2011 Aug; 665(1-3):29-39. PubMed ID: 21554873
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma expression in CD8+ T cells regulated by IL-6 signal is involved in superantigen-mediated CD4+ T cell death.
Atsumi T; Sato M; Kamimura D; Moroi A; Iwakura Y; Betz UA; Yoshimura A; Nishihara M; Hirano T; Murakami M
Int Immunol; 2009 Jan; 21(1):73-80. PubMed ID: 19050105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
